Literature DB >> 12862499

Differential diagnosis of severe cutaneous drug eruptions.

Nicolas Bachot1, Jean-Claude Roujeau.   

Abstract

Adverse cutaneous reactions to drugs are frequent, mostly secondary to antibacterials, however, serious adverse cutaneous reactions are infrequent. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are a spectrum of the same disease. They are the more severe drug eruptions, with a mortality around 30% for TEN. The confusion between erythema multiforme major and SJS means that erythema multiforme major is the main differential diagnosis. Skin disorders involving desquamation, in particular after pustulosis, are also common differential diagnoses. Mechanical or autoimmune blistering are also potential misdiagnoses of TEN/SJS. Hypersensitivity Syndrome (HSS) or Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) is a severe cutaneous drug reaction with often a long duration of eruption and serious other organ involvement. Exfoliative dermatitis, whether caused by psoriasis, dermatitis or lymphoma, can be thought of as a differential diagnosis of DRESS/HSS. Angio-immunoblastic lymphadenopathy, viral eruption and vasculitis are other differential diagnoses of DRESS/HSS. Prompt recognition of a severe drug reaction and withdrawal of the culprit drug is often the most important therapeutic action. Alternatively, a delay in starting a specific treatment for a disease misdiagnosed as a drug eruption could be deleterious.

Entities:  

Mesh:

Year:  2003        PMID: 12862499     DOI: 10.2165/00128071-200304080-00006

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  26 in total

1.  [Not Available].

Authors:  S Siah; A Baite; H Bakkali; M Atmani; K Ababou; H Ihrai
Journal:  Ann Burns Fire Disasters       Date:  2009-09-30

Review 2.  My approach to superficial inflammatory dermatoses.

Authors:  K O Alsaad; D Ghazarian
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

3.  Phenobarbital-induced bullous lesions in a non-comatose patient.

Authors:  Michael Keng; Maritza Lagos; Michael R Liepman; Kimberly Trever
Journal:  Psychiatry (Edgmont)       Date:  2006-12

4.  Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England.

Authors:  Deborah Layton; Vanessa Marshall; Andrew Boshier; Peter Friedmann; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 5.  General principles of investigating and managing drug allergy.

Authors:  Anthony Frew
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

6.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

7.  A case of toxic epidermal necrolysis (ten) with severe chronic ocular complications in a healthy 46-year-old woman.

Authors:  A Voltan; B Azzena
Journal:  Ann Burns Fire Disasters       Date:  2010-06-30

8.  [Dithiols as chelators. A cause of bullous skin reactions].

Authors:  J Storim; J Stoevesandt; D Anders; H Kneitz; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2011-03       Impact factor: 0.751

9.  A case of hypersensitivity syndrome to both vancomycin and teicoplanin.

Authors:  Hyouk-Soo Kwon; Yoon-Seok Chang; Yi-Yeong Jeong; Sang-Min Lee; Woo-Jung Song; Hong-Bin Kim; Yoon-Keun Kim; Sang-Heon Cho; You-Young Kim; Kyung-Up Min
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

10.  Acute management of Stevens-Johnson syndrome and toxic epidermal necrolysis to minimize ocular sequelae.

Authors:  Scheffer C G Tseng
Journal:  Am J Ophthalmol       Date:  2009-06       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.